The U.S. Army yesterday issued a revised and updated safety policy for microbiology and biomedical laboratories. The new policy “prescribes the technical safety requirements for the use, handling, transportation, transfer, storage, and disposal of infectious agents and toxins (IAT) rated at biosafety level 2 (BSL–2) and above.” It applies to “all U.S. Army activities and facilities in which IAT are used.”
“Microbiological and biomedical activities are conducted by the U.S. Army in developing measures to identify, detect, diagnose, treat, and protect against IAT,” the 45 page document explains. See “Safety Standards for Microbiological and Biomedical Laboratories” (pdf), U.S. Army Pamphlet 385-69, May 6, 2009.
The transition to a clean energy future and diversified sources of energy requires a fundamental shift in how we produce and consume energy across all sectors of the U.S. economy.
A deeper understanding of methane could help scientists better address these impacts – including potentially through methane removal.
While it is reasonable for governments to keep the most sensitive aspects of nuclear policies secret, the rights of their citizens to have access to general knowledge about these issues is equally valid so they may know about the consequences to themselves and their country.
Advancing the U.S. leadership in emerging biotechnology is a strategic imperative, one that will shape regional development within the U.S., economic competitiveness abroad, and our national security for decades to come.